drugset / Trial / NCT01645176
Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study of a combination therapy of hydroxychloroquine and atorvastatin is to learn about the effects in inflammation and pain in patients with Osteoarthritis of the knee. These medications are FDA approved and commercially available.
Timeline
- Start
- 2012-05
- Primary completion
- 2016-04
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |
| Subject | Hydroxychloroquine | Small molecule | 200 mg | — |
| Subject | Hydroxychloroquine | Small molecule | 600 mg | — |